Trials / Conditions / Drug Susceptible Pulmonary Tuberculosis
Drug Susceptible Pulmonary Tuberculosis
3 registered clinical trials studyying Drug Susceptible Pulmonary Tuberculosis — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in NCT07517445 | Gates Medical Research Institute | Phase 2 |
| Not Yet Recruiting | Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis NCT07525427 | Gates Medical Research Institute | Phase 2 |
| Not Yet Recruiting | Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-S NCT07129629 | Shanghai Pulmonary Hospital, Shanghai, China | Phase 2 |